MENU

Articles for Shire (LSE: SHP)

One dirt-cheap FTSE 100 stock I’d buy today and one I’d sell

Royston Wild looks at two FTSE 100 (INDEXFTSE: UKX) shares with very different investment outlooks. More »

Why I’d pile into FTSE 100 takeover candidate Shire along with this promising life science play

FTSE 100 (INDEXFTSE: UKX) pharmaceutical firm Shire plc (LON: SHP) still looks attractive to me alongside this potential grower. More »

Two FTSE 100 growth stocks I’d buy with £2,000 today

These two FTSE 100 (INDEXFTSE: UKX) shares could offer growth at a reasonable price. More »

One ‘secret’ growth stock I’d buy alongside this FTSE 100 growth monster

This hidden growth stock is gearing up to become the next FTSE 100 (INDEXFTSE:UKX) growth champion. More »

Looking to invest £2,000? Here are 2 pharma stocks I’d buy today

Harvey Jones says these two pharmaceutical stocks have something to please both momentum and contrarian investors. More »

2 top FTSE 100 defensive stocks for bargain hunting investors

Wide moats to entry, high growth potential and attractive valuations have these FTSE 100 (INDEXFTSE: UKX) stocks at the top of my watch list.... More »

2 pharma stocks I’d buy in March

G A Chester discusses two stocks he'd buy in the under-performing pharmaceuticals sector. More »

2 bargain pharma stocks I’d buy today

Roland Head highlights two pharmaceutical picks you might not have considered. More »

Is now the time to buy this battered Footsie pharma stock?

Royston Wild looks at a troubled FTSE 100 (INDEXFTSE: UKX) stock and asks: could a share price turnaround be just around the corner? More »

2 stocks I’d invest £1,000 in for the long term

These two shares could deliver high returns in the coming years. More »

1 defensive stock I’d buy alongside FTSE 100 peer Shire plc

The sell-off in defensive stocks is throwing up opportunities like Shire (LON SHP) and this share. More »

Could this year’s biggest FTSE 100 fallers be 2018’s biggest winners?

These FTSE 100 (INDEXFTSE:UKX) duds have stunning recovery potential. I've got my eye on two in particular. More »

2 opportunities to make a million?

Could these two shares deliver significant capital growth in future? More »

Why Motif Bio plc is a growth bargain I’d buy and hold for 25 years

Motif Bio PLC (LON: MTFB) has a bright outlook but growth will take time. More »

One FTSE 100 turnaround stock I’d buy and one I’d sell

Roland Head looks takes a bold view on two battered FTSE 100 (INDEXFTSE:UKX) stocks. More »

2 beaten-up FTSE 100 stocks: is now the time to buy?

Edward Sheldon looks at two FTSE 100 (INDEXFTSE:UKX) stocks that are way off their highs. Are these stocks now bargains? More »

This small-cap growth stock could be a millionaire-maker

Bilaal Mohamed believes this hidden gem could help you on the road to riches. More »

Why I think Indivior plc is a growth stock for shrewd investors

You shouldn't count out Indivior plc (LSE: INDV) just yet. More »

2 bargain recovery stocks that could make you brilliantly rich

These two shares offer wide margins of safety. More »

Why this battered pharma stock could be a top turnaround buy

Roland Head selects his turnaround pick from two of this year's biggest pharma fallers. More »